Drugs Home > Belatacept Dosage

Before prescribing a specific belatacept dosage, your healthcare provider will need to know how much you weigh. This medication comes in the form of an intravenous (IV) injection that is administered by a healthcare provider. You will receive several infusions during the first 16 weeks after your kidney transplant, and then infusions will be administered every four weeks as a maintenance dose.

An Introduction to Your Dosage of Belatacept

The dosage of belatacept (NULOJIX®) your healthcare provider recommends will vary, depending on your weight. As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.

Belatacept Dosing Guidelines

The initial dosage of belatacept for preventing kidney transplant rejection is usually 10 mg per kg body weight (about 4.5 mg per lb) starting the day of the transplant surgery. A second dosage will be given about four days later (approximately 96 hours after the first dose), followed by doses given 2, 4, 8, and 12 weeks after surgery.
Belatacept maintenance dosing will begin 16 weeks after surgery. The usual recommended maintenance dose of belatacept is 5 mg per kg (about 2.3 mg per lb) approximately every four weeks (every 25 to 31 days).

General Information on Receiving Belatacept

Some considerations to keep in mind during treatment with belatacept include the following:
  • This medication is given as a slow injection into a vein (an intravenous, or IV, infusion). You will receive your first dose the day of your surgery.
  • A healthcare provider will administer your injection in a healthcare setting, such as a hospital or clinic. It will take approximately 30 minutes to administer each dose.
  • For this drug to work properly, it must be taken as prescribed. Make sure to keep all of your appointments with your healthcare provider.
  • If you are unsure about anything related to your dosage or belatacept dosing in general, please talk to your healthcare provider or pharmacist.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.